A Prospective, Open Label, Post Marketing Surveillance Study Following Transfusion of INTERCEPT Platelet Components

Disease Sites:

Hematologic

Staging:

Phase IV

Age Group:

Both

Therapies:

Not Available

Drugs:

Not Available

Principal Investigator(s):

Young, Pampee

Scope:

National

Participating Institutions:

Vanderbilt University

Open Date:

01-19-2016

Objective:

Prospect, OL, Post Marketing Surveillance Stdy Following Transfusion INTERCEPT Platelet Components

Trial Type:

Other

Protocol ID:

VICCBMT15130

National Clinical Trial ID:

NCT02549222

Eligibility

Ages Eligible for Study:

Not Available

Genders Eligible for Study:

Not Available

Accepts Healthy Volunteers?:

Not Available